Exhibit 107
Calculation of Filing Fee Table
Form S-3
(Form Type)
Tango Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Share (2) | Maximum Price | Fee Rate | Amount of Registration Fee (3) | |||||||||
Fees to be paid | Equity | Common Shares, par value $0.001 per share | 457(c) | 15,537,250 shares | $6.93 | $107,673,142.50 | $0.0001102 | $11,865.58 | ||||||||
Total Offering Amounts | $107,673,142.50 | — | ||||||||||||||
Total Fees Previously Paid | — | |||||||||||||||
Total Fee Offsets | — | |||||||||||||||
Net Fee Due | $11,865.58 |
(1) | Consists of (i) 13,196,671 shares of the registrant’s common stock and (ii) 2,340,579 shares issuable upon the exercise of pre-funded warrants, by the selling shareholders named in the prospectus contained herein. Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this registration statement also covers such additional shares as may hereafter be offered or issued to prevent dilution resulting from stock splits, stock dividends, recapitalizations or certain other capital adjustments. |
(2) | Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act of 1933, as amended. The price per share and aggregate offering price are based on the average of the high and low prices of the registrant’s common stock on August 30, 2023, as reported on Nasdaq. |
(3) | Calculated pursuant to Section 6(b) of the Securities Act. |